Skip to main content
SpringerLink
Log in

Pituitary Hyperplasia

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Comprehensive article summarizing more than 25 years of experience with pituitary hyperplasia in surgical material. Morphologic forms of hyperplasia<197>diffuse and nodular<197>are defined and, for comparison, the normal morphology, frequency and intraglandular distribution of cell types are briefly reviewed. All cell types can give rise to hyperplasia, although their frequency, extent and clinical importance widely vary. Somatotroph hyperplasia is rare; it is limited to cases of GHRH overproduction by extrapituitary endocrine neoplasms and sporadic examples of gigantism. Prolactin cells display the highest propensity for non-neoplastic proliferation. Physiologic hyperplasia occurs in pregnancy and lactation. Pathological hyperplasia is mostly secondary to other, neoplastic or non-neoplastic, space occupying processes. Idiopathic lactotroph hyperplasia is very rare. The much-disputed corticotroph hyperplasia is infrequent cause of pituitary dependent Cushing's disease. Despite difficulties of diagnosis in fragmented biopsies, several well-documented cases prove the existence of corticotroph hyperplasia which is nearly always nodular. Thyrotroph hyperplasia, secondary to hypothyroidism, a treatable condition, is not expected to occur in surgical material, yet several cases have been identified. Operated lesions are massive nodular leading to significant pituitary enlargement thereby mimicking TSH- or PRL-producing adenoma. Hyperprolactinemia is a frequent concomitant of severe thyrotroph hyperplasia. Gonadotroph hyperplasia and proliferation of pars intermedia derived POMC cells are not likely to occur in surgical material and have no clinical significance. Adenoma formation may rarely be associated with any type of pituitary hyperplasia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kovacs K, Horvath E. Atlas of Tumor Pathology, Series 2, Fasc. 21, Tumors of the Pituitary Gland. DC: Armed Forces of Institute of Pathology, Washington, DC: 1986.

    Google Scholar 

  2. Horvath E, Kovacs K. Fine structural cytology of the adenohypophysis in rat and man. J Electr Micr Techn 1988;8: 401–432.

    Google Scholar 

  3. Horvath E, Kovacs K. Ultrastructural diagnosis of pituitary adenomas and hyperplasias. In: Lloyd RV, ed. Surgical Pathology of the Pituitary Gland. Philadelphia: WB Saunders, 1993;27:52–84.

    Google Scholar 

  4. Horvath E, Scheithauer BW, Kovacs K, Lloyd RV. Regional neuropathology: Hypothalamus and pituitary. In: Graham DI, Lantos PL (eds). Greenfield' Neuropathology. London: Arnold, 1997;1007–1082.

    Google Scholar 

  5. Horvath E, Kovacs K. The adenohypophysis. In: Kovacs K, Asa SL (eds). Functional Endocrine Pathology. Malden, Maryland: Blackwell Science, 1998;247–281.

    Google Scholar 

  6. Bloodworth JMB Jr. Assessment of pituitary hyperplasia/neoplasia interface. Pathology, Research & Practice 1988;183: 626–630.

    Google Scholar 

  7. Thorner MO, Perryman RL, Cronin MJ, et al. Somatotroph hyperplasia. J Clin Invest 1982;70:965–977.

    Google Scholar 

  8. Scheithauer BW, Carpenter PC, Bloch B, Brazeau P. Ectopic secretion of a growth hormone-releasing factor. Report of a case of acromegaly with bronchial carcinoid tumor (review). Am J Med 1984;76:605–616.

    Google Scholar 

  9. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: Clinical, biochemical and morphologic manifestations. Endocrine Rev 1988;9:357–373.

    Google Scholar 

  10. Caron P, Guittard J, Trouillas J, Salvador M, Bayard F. Acro megalie et tumeur carcinoide bronchique. A propos d'une observation. Ann d'Endocrinol 1992;53:158–161.

    Google Scholar 

  11. Ezzat S, Asa SL, Stefaneanu L, et al. Somatotroph hyperplasia without pituitary adenoma associated with a longstanding growth hormone-releasing hormone-producing bronchial carcinoid. J Clin Endocrinol Metab 1994;78:555–560.

    Google Scholar 

  12. Sanno N, Teramoto A, Osamura RY, Genka S, Katakami H, Jin L, Lloyd RV, Kovacs K. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly. J Clin Endocrinol Metab 1997; 82:2731–2737.

    Google Scholar 

  13. Moran A, Asa SL, Kovacs K, et al. Gigantism due to pituitary mammosomatotroph hyperplasia. New Engl J Med 1990;323:322–326.

    Google Scholar 

  14. Zimmerman D, Young WF Jr, Ebersold MJ, et al. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation. J Clin Endocrinol Metab 1993;76:216–222.

    Google Scholar 

  15. Kovacs K, Horvath E, Thorner MO, Rogol AD. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome: A histologic, immunocytologic and ultrastructural study of the surgically-removed adenohypophysis. Virchows Archiv 1984;403:77–86.

    Google Scholar 

  16. Scheithauer BW, Sano T, Kovacs K, Young WF Jr, Ryan N, Randall RV. The pituitary gland in pregnancy: A clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990;65:461–474.

    Google Scholar 

  17. Asa SL, Penz G, Kovacs K, Ezrin C. Prolactin cells in the human pituitary. Arch Pathol Lab Med 1982;106:360–363.

    Google Scholar 

  18. Coogan PF, Baron JA, Lambe M. Parity and pituitary adenoma risk. J Nat Cancer Inst 1995;87:1410–1411.

    Google Scholar 

  19. Scheithauer BW, Kovacs K, Randall RV, Ryan NM. The effects of estrogen on the human pituitary: a clinicopathologic study. Mayo Clin Proc 1989;64:1077–1084.

    Google Scholar 

  20. Kovacs K, Stefaneanu L, Ezzat S. Prolactin-producing pituitary adenoma in a male to female transsexual patient with protracted estrogen administration. A morphologic study. Arch Pathol Lab Med 1994;118:562–565.

    Google Scholar 

  21. Cusimano MD, Kovacs K, Bilbao JM, Tucker WS, Singer W. Suprasellar craniophyaryngioma associated with hyperprolactinemia, pituitary lactotroph hyperplasia, and microprolactinoma. J. Neurosurg 1988;69:620–623.

    Google Scholar 

  22. Saiardi A, Bozzi Y, Baik JH, Borrelli E. Antiproliferative role of dopamine: Loss of D2 receptors causes hormonal dysfunction and pituitary hyperplasia. Neuron 1997; 19:115–126.

    Google Scholar 

  23. Grubb MR, Chakeres D, Malarkey WB. Patients with primary hypothyroidism presenting as prolactinomas. Amer J Med 1987;83:765–769.

    Google Scholar 

  24. Abram M, Brue T, Morange I, Girard N, Guibout M, Jaquet P. Syndrome tumoral hypophysaire et hyperprolactinemie dans l'hypothyroidie peripherique. Ann d'Endocrinol 1992; 53:215–223.

    Google Scholar 

  25. Jay V, Kovacs K, Horvath E, Lloyd RV, Smyth HF. Idiopathic prolactin cell hyperplasia of the pituitary mimicking prolactin cell adenoma: A morphological study including immunocytochemistry, electron microscopy and in situ hybridization. Acta Neuropathol (Berl) 1991;82:147–151.

    Google Scholar 

  26. Peillon F, Dupuy M, Kujas M, Vincens M, Mowszowlex L, Derome P. Pituitary enlargement with suprasellar extension in functional hyperprolactinemia due to lactotroph hyperplasia: A pseudotumoral disease. J Clin Endocrinol Metab 1991;73:1008–1015.

    Google Scholar 

  27. Saeger W, Ludecke DK. Pituitary hyperplasia. Definition, light, and electron microscopic structures and significance in surgical specimens. Virchows Arch Pathol Anat 1983;399: 277–287.

    Google Scholar 

  28. Saeger W. Surgical pathology of the pituitary in Cushing' disease. Pathol Res Pract 1991;187:613–616.

    Google Scholar 

  29. Trouillas J, Guigard MP, Fonlupt P, Souchier C, Girod C. Mapping of corticotropic cells in the normal human pituitary. J Histochem Cytochem 1996;44:473–479.

    Google Scholar 

  30. Horvath E, Kovacs K, Lloyd RV. Pars intermedia of the human pituitary revisited: Morphologic aspects and frequency of hyperplasia of POMC-peptide immunoreactive cells. Endocr Pathol; in press.

  31. Rasmussen AT. Origin of the basophilic cells in the posterior lobe of the human hypophysis. Amer J Anat 1930;46:461–475.

    Google Scholar 

  32. Schnall AM, Kovacs K, Brodkey JS, Pearson OH. Pituitary Cushing' disease without adenoma. Acta Endocrinol 1980;94:297–303.

    Google Scholar 

  33. McNicol AM. Patterns of corticotrophic cells in the adult human pituitary in Cushing' disease. Diagn Histopathol 1981;4:335–341.

    Google Scholar 

  34. McKeever PE, Koppelman MCS, Metcalf D, et al. Refractory Cushing' disease caused by multinodular ACTH-cell hyperplasia. J Neuropathol Exp Neurol 1982;41:490–499.

    Google Scholar 

  35. Lloyd RV, Chandler WF, McKeever PE, Schteingart DE. The spectrum of ACTH-producing pituitary lesions. Am J Surg Pathol 1986;10:618–626.

    Google Scholar 

  36. Young WF Jr, Scheithauer BW, Gharib H, et al. Cushing' syndrome due to primary multinodular corticotropic hyperplasia. Mayo Clin Proc 1988;63:256–262.

    Google Scholar 

  37. Lamberts SWJ, Stefanko SZ, DeLange SA, et al. Failure of clinical remission after trans-sphenoidal removal of a microadenoma in a patient with Cushing' disease: Multiple hyperplastic and adenomatous cell nests in surrounding pituitary tissue. J Clin Endocrinol Metab 1980;50:793–795.

    Google Scholar 

  38. Carey RM, Varma SK, Drake CR, et al. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing' syndrome: A clinical, morphologic, and biochemical study. N Engl J Med 1984;311:13–20.

    Google Scholar 

  39. Schteingart DE, Lloyd RV, Akil H, Chandler WF, Ibarra-Perez G, Rosen SG, Ogletree R. Cushing' syndrome secondary to ectopic corticotropin-releasing hormone-adrenocorticotropin secretion. J Clin Endocrinol Metab 1986;63: 770–775.

    Google Scholar 

  40. O'Brien T, Young WF Jr, Davila DG, et al. Cushing' syndrome associated with ectopic production of corticotropinreleasing hormone, corticotropin, and vasopressin by a pheochromocytoma. Clin Endocrinol 1992;37:460–467.

    Google Scholar 

  41. Scheithauer BW, Kovacs K, Randall RV. The pituitary gland in untreated Addison' disease. A histologic and immunocytologic study of 18 adenohypophyses. Arch Patho Lab Med 1983;107:484–487.

    Google Scholar 

  42. Scheithauer BW, Kovacs K, Randall RV, Ryan N. Pituitary gland in hypothyroidism: histologic and immunocytologic study. Arch Pathol Lab Med 1985;109:499–504

    Google Scholar 

  43. Ahmed M, Banna M, Sakati N, Woodhouse N. Pituitary gland enlargement in primary hypothyroidism: A report of 5 cases with follow-up data. Horm Res 1989;32:188–192.

    Google Scholar 

  44. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. Thyrotropin-secreting pituitary tumors. Endocr Rev 1996;17:610–638.

    Google Scholar 

  45. Beck-Peccoz P, Persani L, Asteria C, Cortelazzi D, Borgato S, Mannavola D, Romoli R. Thyrotropin-secreting pituitary tumors in hyper-and hypothyroidism. Acta Medica Austriaca 1996;23:41–46.

    Google Scholar 

  46. Sartis NJ, Brucker-Davis F, Doppman H, Skarulis MC. MRI-demonstrable regression of a pituitary mass in a case of primary hypothyroidism after a week of acute thyroid hormone therapy. J Clin Endocrinol Metab 1997;82:808–811.

    Google Scholar 

  47. Horvath E, Kovacs K, Scheithauer BW. Surgical pathology of pituitary thyrotroph hyperplasia: An oxymoron? Endocr Pathol 1992;3:(Suppl.1)514–515.

    Google Scholar 

  48. Khalil A, Kovacs K, Sima AAF, Burrow GN, Horvath E. Pituitary thyrotroph hyperplasia mimicking prolactin-secreting adenoma. J Endocrinol Invest 1984;7:399–404

    Google Scholar 

  49. Pioro EP, Scheithauer BW, Laws ER Jr, et al. Combined thyrotroph and lactotroph cell hyperplasia simulating prolactin-secreting pituitary adenoma in long-standing primary hypothyroidism. Surg Neurol 1988;29:218–226.

    Google Scholar 

  50. Okuda K, Yoshikawa M, Ushiroyama T, Sugimoto O, Maeda T, Mori H. Two patients with hypergonadotropic ovarian failure due to to pituitary hyperplasia. Obstetrics and Gynecology 1989;74:498–501.

    Google Scholar 

  51. Riedl S, Frisch H. Pituitary hyperplasia in a girl with gonadal dysgenesis and primary hypothyroidism. Horm Res 1997;47:126–130.

    Google Scholar 

  52. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER. Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody. Neurosurgery 1996;38:99–107.

    Google Scholar 

  53. Severinghaus AE. Cellular changes in the anterior hypophysis with special references to its secretory activities. Physiol Rev 1937;17:556–588.

    Google Scholar 

  54. Frawley LS, Boockfor FR. Mammosomatotropes: Presence and functions in normal and neoplastic pituitary tissue. Endocr Rev 1991;12:337–355.

    Google Scholar 

  55. Stefaneanu L, Kovacs K, Lloyd RV, Scheithauer BW, Young WF Jr, Sano T, Jin L. Pituitary lactotrophs and somatotrophs in pregnancy: a correlative in situ hybridization and immunocytochemical study. Virchows Archiv B, Cell Pathol 1992;62:291–296.

    Google Scholar 

  56. Horvath E, Lloyd RV, Kovacs K. Propylthiouracyl-induced hypothyroidism results in reversible transdifferentiation of somatotrophs into thyroidectomy cells.Amorphologic study of the rat pituitary including immunoelectron microscopy. Lab Invest 1990;63:511–520.

    Google Scholar 

  57. Vidal S, Horvath E, Kovacs K, Cohen SM, Lloyd RV, Scheithauer BW. Transdifferentiation of somatotrophs to thyrotrophs in the pituitary of patients with protracted primary hypothyroidism. Submitted for publication.

  58. DeLellis RA, Tischler AS. The dispersed neuroendocrine cell system. In: K Kovacs, SL Asa (eds). Functional Endocrine Pathology, Second Ed., Malden, MA: Blackwell Science, 1998:529–549.

    Google Scholar 

  59. Bordi C, D'Adda T, Azzoni C, Canavese G, Brandi ML. Gastrointestinal endocrine tumors: Recent developments. Endocr Pathol 1998;9:99–115.

    Google Scholar 

  60. Thapar K, Kovacs K, Stefaneanu L, Scheithauer BW, Killinger DW, Lloyd RV, Smyth HS, Barr A, Thorner MO, Gaylinn B, Laws ER Jr: Overexpression of the growth hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behaviour. Am J Pathol 1997;151:769–784.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Laboratory Medicine, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada

    Eva Horvath & Kalman Kovacs

  2. Department of Laboratory Medicine, Mayo Clinic, Rochester, Minnesota, USA

    Bernd Scheithauer

Authors
  1. Eva Horvath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kalman Kovacs
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernd Scheithauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horvath, E., Kovacs, K. & Scheithauer, B. Pituitary Hyperplasia. Pituitary 1, 169–179 (1999). https://doi.org/10.1023/A:1009952930425

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009952930425

Search

Navigation